Jenburkt Pharmaceuticals Limited (BOM:524731)

Jenburkt Pharmaceuticals Revenue

Jenburkt Pharmaceuticals had revenue of 368.93M INR in the quarter ending December 31, 2024, with 3.46% growth. This brings the company's revenue in the last twelve months to 1.49B, up 8.07% year-over-year. In the fiscal year ending March 31, 2024, Jenburkt Pharmaceuticals had annual revenue of 1.42B with 3.82% growth.

• Revenue (ttm): 1.49B
• Revenue Growth: +8.07%
• P/S Ratio: 3.25
• Revenue / Employee: 1.99M
• Employees: 752
• Market Cap: 4.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	1.42B	52.17M	3.82%
Mar 31, 2023	1.37B	127.69M	10.30%
Mar 31, 2022	1.24B	146.86M	13.44%
Mar 31, 2021	1.09B	-95.97M	-8.07%
Mar 31, 2020	1.19B	-37.53M	-3.06%